Speaker
Description
Magnetic nanoparticles (MNPs) are widely used in biomedical applications, including their role as hyperthermic agents for tumor treatment via Magnetic Fluid Hyperthermia (MFH) and as tracers in Quantitative Susceptibility Mapping (QSM).
In MFH, MNPs exposed to an alternating magnetic field generate localized heat within pathological tissues, enabling targeted thermal therapy. QSM is an advanced Magnetic Resonance Imaging (MRI) post-processing technique that reconstructs spatial maps of tissue magnetic susceptibility from phase data by solving an inherently ill-posed inverse problem.
Our research group investigates hyperthermia treatments combined with hadron therapy in three-dimensional tissue models, aiming to evaluate potential synergistic effects that could enhance therapeutic efficacy.
Within the QSM framework, we focus on tracking vesicles used as vehicles for targeted drug delivery in the treatment of neurodegenerative diseases. In this context, QSM enables the quantification of iron distribution, emerging as a powerful tool for mapping vesicle localization and concentration.